Evaluation of antifungal therapy in patients with candidaemia based on susceptibility testing results: implications for antimicrobial stewardship programmes | Zendy

Dhara N. Shah | Zendy; Raymond Yau | Zendy; Jaye Weston | Zendy; Todd Lasco | Zendy; Miguel Salazar | Zendy; Hannah R. Palmer | Zendy; Kevin W. Garey | Zendy

Open Access

Evaluation of antifungal therapy in patients with candidaemia based on susceptibility testing results: implications for antimicrobial stewardship programmes

Author(s) -

Dhara N. Shah,

Raymond Yau,

Jaye Weston,

Todd Lasco,

Miguel Salazar,

Hannah R. Palmer,

Kevin W. Garey

Publication year - 2011

Publication title -

journal of antimicrobial chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.124

H-Index - 194

eISSN - 1460-2091

pISSN - 0305-7453

DOI - 10.1093/jac/dkr244

Subject(s) - fluconazole , echinocandin , medicine , micafungin , mycosis , antifungal , fungemia , surgery , dermatology

Definitive antifungal therapy is typically based on Candida species and clinical status, rather than susceptibility reports. Antifungal susceptibility testing is available, but the impact on treatment decisions is unknown. The purpose of this study was to assess antifungal therapy in hospitalized patients with candidaemia during the time period between the start of empirical therapy and after antifungal susceptibility testing reports are available.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research